A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement

Published:2021-12-02 Issue: Volume: Page:1-3
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Doi Yukiko¹^ORCID,Yokota Takafumi¹,Shibayama Hirohiko¹^ORCID,Matsumoto Kana²,Kurashige Masako³,Nozaki Kenji¹,Fujita Jiro¹,Fukushima Kentaro¹,Hosen Naoki¹

Affiliation:

1. Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan

2. Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyoto, Japan

3. Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan

Funder

Celgene, Mundipharma International

Takeda Pharmaceutical Company

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2005043

Reference9 articles.

1. Primary CNS T-cell Lymphomas

2. Aggressive T‐cell lymphomas: 2019 updates on diagnosis, risk stratification, and management

3. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

4. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study

5. Whole‐exome sequencing identified mutational profile of a case with T‐cell chronic lymphocytic leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP